Great work, team! Our participants are truly amazing. 👏

📢 Join Dr. Wendy Chung, Principal Investigator of Simons Searchlight, as she speaks on "Scaling Understanding, Advancing Care, and Developing Treatments for Rare Genetic Conditions." Don't miss this talk at the International Center for Genetic Disease speaker series. Register ➡️ bit.ly/3X7gqcg

Looking forward to speaking at Harvard Medical School's Keynote Series on Genomic Medicine! If you're able, register for my talk on 6/21 at 10am — Scaling Understanding, Advancing Care, and Developing Treatments for Rare Genetic Conditions: bit.ly/3p4JJzC *Open free academic event

Pulmonary arterial hypertension: which genes are important for genetic diagnoses? Our ClinGen PH expert panel provides clinical classification of 27 genes, including 12 definitive genes and 5 disputed genes. The Pulmonary Vascular Research Institute The Pulmonary Hypertension Association TBX4Life #PAH sciencedirect.com/science/articl…

The historic approval of the first gene editing therapy for sickle cell disease is a moment to celebrate! We’re proud have played a big part in developing this potentially curative treatment. Follow the timeline of discovery: answers.childrenshospital.org/sickle-cell-fe…

The first gene editing therapy for sickle cell disease, just approved by the FDA, has a long backstory. Much science – starting 75 years ago – went into making creating this potentially curative treatment. It all revolves around fetal hemoglobin: answers.childrenshospital.org/sickle-cell-fe…

Episode 117 of The Genetics Podcast is live! 🚀 We’re joined by Harvard Medical School professor & Doctor, Wendy Chung. Tune in to hear how a new study offering whole genome sequencing at birth is helping families make pioneering #healthcare decisions 👇 pod.fo/e/21235a

Enormously proud and honored to do this important work. ❤️

🎙️ ICYMI: Our fearless leader, Dr. Wendy Chung, talks precision medicine with Dr. Jeff Skibitsky on the ABS Kids 'Autism Weekly' podcast! Watch here: youtube.com/watch?v=Mx0DQl…

What an incredible day! Honored to have been invited. #RareDiseaseDay

join me on May 11 to hear more about newborn screening for cardiomyopathy pcmconf.org #cardiomyopathy #earlydiagnosis

bit.ly/4aS5G6U 👈 Be sure to catch #SPARKintheNews with Dr. Wendy Chung's latest piece for @STATNews: "Autism doesn't discriminate. Autism research shouldn't either."

fresh off the press- The Clinical Geneticist Workforce: Community Forums to Address Challenges and Opportunities sciencedirect.com/science/articl…

Intrathecal antisense oligonucleotide therapy for one patient with KIF1A associated neurological disorder (KAND) shows promise as a safe and effective treatment that improves or stabilizes multiple disease symptoms. #KIF1A #therapy nature.com/articles/s4159…

In celebration of Newborn Screening Awareness Month, GeneDx is hosting a live conversation on the critical role of newborn screening—plus the latest from the GUARDIAN study, which screens newborns using genome sequencing. Join us on Sept. 26 at 1:00 pm ET: genedx.co/4d0sbr5

Honored to accept the 2024 RARE Champion of Hope in Health Equity award. Recognition that celebrates those making a sig impact in overcoming systemic & organizational challenges contributing to inequities in the rare disease community. It is a tribute to the many who work with me

Exciting news! Initial findings of the GUARDIAN study have been published ja.ma/4f8XNwN showcasing the feasibility of DNA sequencing based expanded newborn screening for early detection of treatable conditions. full announcement lnkd.in/en6AMGtk

Exploring the future of newborn screening with genome sequencing, we highlight how the lessons learned from GUARDIAN and other studies are shaping a pathway toward universal and equitable genomic screening. To learn more: rdcu.be/dX9FB #GUARDIANStudy

Proud to lead @S_Searchlight as we mark 15 years of progress. Grateful to the families and researchers who make this work possible—we’ve come so far, and there’s more to do. ✨ Learn more: bit.ly/WendyChung15Ye… #SimonsSearchlight15 #RareGenetics #15YearsOfProgress

Looking forward to this! See you there.